
### [MONDO:0015722](http://purl.obolibrary.org/obo/MONDO_0015722)
**Label:** congenital vitamin K-dependent coagulation factors deficiency

**Subclasses:** [MONDO:0011837](http://purl.obolibrary.org/obo/MONDO_0011837) (vitamin K-dependent clotting factors, combined deficiency of, type 2), [MONDO:0010187](http://purl.obolibrary.org/obo/MONDO_0010187) (vitamin K-dependent clotting factors, combined deficiency of, type 1), [MONDO:0013361](http://purl.obolibrary.org/obo/MONDO_0013361) (prothrombin deficiency), [MONDO:0009211](http://purl.obolibrary.org/obo/MONDO_0009211) (congenital factor VII deficiency), [MONDO:0009212](http://purl.obolibrary.org/obo/MONDO_0009212) (congenital factor X deficiency), 

**Corr. equiv. classes:** [OMIM:277450](http://purl.obolibrary.org/obo/OMIM_277450), [OMIM:227500](http://purl.obolibrary.org/obo/OMIM_227500), [Orphanet:328](http://www.orpha.net/ORDO/Orphanet_328), [Orphanet:327](http://www.orpha.net/ORDO/Orphanet_327), [OMIM:227600](http://purl.obolibrary.org/obo/OMIM_227600), [OMIM:613679](http://purl.obolibrary.org/obo/OMIM_613679), [Orphanet:98434](http://www.orpha.net/ORDO/Orphanet_98434), [OMIM:607473](http://purl.obolibrary.org/obo/OMIM_607473), [Orphanet:325](http://www.orpha.net/ORDO/Orphanet_325), 

**Class expressions from DL-Learner:**

- [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) and [HP:0012243](http://purl.obolibrary.org/obo/HP_0012243) (Abnormal reproductive system morphology) 66.67%
- [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) and [HP:0011830](http://purl.obolibrary.org/obo/HP_0011830) (Abnormality of oral mucosa) 66.67%
- [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) and [HP:0010460](http://purl.obolibrary.org/obo/HP_0010460) (Abnormality of the female genitalia) 66.67%
- [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) 66.67%
- [HP:0002597](http://purl.obolibrary.org/obo/HP_0002597) (Abnormality of the vasculature) and [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000858](http://purl.obolibrary.org/obo/HP_0000858) (Menstrual irregularities) and [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) and [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000812](http://purl.obolibrary.org/obo/HP_0000812) (Abnormal internal genitalia) and [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) and [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000366](http://purl.obolibrary.org/obo/HP_0000366) (Abnormality of the nose) and [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000234](http://purl.obolibrary.org/obo/HP_0000234) (Abnormality of the head) and [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000225](http://purl.obolibrary.org/obo/HP_0000225) (Gingival bleeding) and [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%
- [HP:0000168](http://purl.obolibrary.org/obo/HP_0000168) (Abnormality of the gingiva) and [HP:0005261](http://purl.obolibrary.org/obo/HP_0005261) (Joint hemorrhage) and [HP:0008151](http://purl.obolibrary.org/obo/HP_0008151) (Prolonged prothrombin time) 66.67%


